FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082626692> ?p ?o ?g. }

• W2082626692 endingPage "190" @default.
• W2082626692 startingPage "181" @default.
• W2082626692 abstract "Dithiiranylmethyloxy azaxanthone (CHO10), which was discovered by screening compounds in a reporter gene assay, inhibited the ESX–Sur2 interaction in a dose-dependent manner with potency similar to canertinib. The intervention of CHO10 during the ESX–Sur2 interaction caused down-regulation of both HER2 gene amplification and HER2 protein expression, which led to the attenuation of HER2-mediated downstream signal cascades and autocrine cell growth in SK-BR-3 cells, which are HER2 overexpressing breast cancer cells. The cell growth inhibitory activity of CHO10 was more potent in HER2-overexpressing breast cancer cells (AU-565, BT474 and SK-BR-3) than in HER2-negative cells (HEK293) and breast cancer cells (MCF-7) that express a basal level of HER2. Treatment with CHO10 in combination with tamoxifen sensitized BT474 cells, tamoxifen-resistant ER-positive breast cancer cell line, toward chemotherapeutic. The anti-tumor activity of CHO10 was validated by the significant reduction in tumor size of NCI-H460 or DLD-1 subcutaneously implanted xenograft tumors through treatment with 1 mg/kg five times every other 2 days." @default.
• W2082626692 created "2016-06-24" @default.
• W2082626692 creator A5019565977 @default.
• W2082626692 creator A5026989459 @default.
• W2082626692 creator A5033468301 @default.
• W2082626692 creator A5035100064 @default.
• W2082626692 creator A5059806376 @default.
• W2082626692 creator A5067207199 @default.
• W2082626692 creator A5068697669 @default.
• W2082626692 creator A5070489074 @default.
• W2082626692 creator A5072784740 @default.
• W2082626692 date "2013-10-01" @default.
• W2082626692 modified "2023-10-17" @default.
• W2082626692 title "Dithiiranylmethyloxy azaxanthone shows potent anti-tumor activity via suppression of HER2 expression and HER2-mediated signals in HER2-overexpressing breast cancer cells" @default.
• W2082626692 cites W1591443723 @default.
• W2082626692 cites W1596261235 @default.
• W2082626692 cites W1956061739 @default.
• W2082626692 cites W1961026612 @default.
• W2082626692 cites W1964063211 @default.
• W2082626692 cites W1967169182 @default.
• W2082626692 cites W1968356815 @default.
• W2082626692 cites W1970657024 @default.
• W2082626692 cites W1974024530 @default.
• W2082626692 cites W1998162919 @default.
• W2082626692 cites W2006806309 @default.
• W2082626692 cites W2021354353 @default.
• W2082626692 cites W2025029381 @default.
• W2082626692 cites W2028072190 @default.
• W2082626692 cites W2030796899 @default.
• W2082626692 cites W2033489089 @default.
• W2082626692 cites W2034770261 @default.
• W2082626692 cites W2040709804 @default.
• W2082626692 cites W2043065181 @default.
• W2082626692 cites W2046878889 @default.
• W2082626692 cites W2050831491 @default.
• W2082626692 cites W2062713892 @default.
• W2082626692 cites W2064536311 @default.
• W2082626692 cites W2066311574 @default.
• W2082626692 cites W2066670766 @default.
• W2082626692 cites W2073376826 @default.
• W2082626692 cites W2077464214 @default.
• W2082626692 cites W2078332829 @default.
• W2082626692 cites W2084356483 @default.
• W2082626692 cites W2087023176 @default.
• W2082626692 cites W2089595068 @default.
• W2082626692 cites W2089770528 @default.
• W2082626692 cites W2090478385 @default.
• W2082626692 cites W2094465857 @default.
• W2082626692 cites W2095156669 @default.
• W2082626692 cites W2104032880 @default.
• W2082626692 cites W2104728809 @default.
• W2082626692 cites W2109388713 @default.
• W2082626692 cites W2109577019 @default.
• W2082626692 cites W2113653056 @default.
• W2082626692 cites W2116323570 @default.
• W2082626692 cites W2124805568 @default.
• W2082626692 cites W2125259474 @default.
• W2082626692 cites W2128003724 @default.
• W2082626692 cites W2128605357 @default.
• W2082626692 cites W2130377362 @default.
• W2082626692 cites W2131824810 @default.
• W2082626692 cites W2134148782 @default.
• W2082626692 cites W2135129680 @default.
• W2082626692 cites W2140046604 @default.
• W2082626692 cites W2143651667 @default.
• W2082626692 cites W2143738177 @default.
• W2082626692 cites W2145553893 @default.
• W2082626692 cites W2145953198 @default.
• W2082626692 cites W2146383973 @default.
• W2082626692 cites W2147934525 @default.
• W2082626692 cites W2156842451 @default.
• W2082626692 cites W2732122454 @default.
• W2082626692 cites W8163034 @default.
• W2082626692 cites W2002462428 @default.
• W2082626692 doi "https://doi.org/10.1016/j.ejps.2013.06.014" @default.
• W2082626692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23835029" @default.
• W2082626692 hasPublicationYear "2013" @default.
• W2082626692 type Work @default.
• W2082626692 sameAs 2082626692 @default.
• W2082626692 citedByCount "12" @default.
• W2082626692 countsByYear W20826266922013 @default.
• W2082626692 countsByYear W20826266922015 @default.
• W2082626692 countsByYear W20826266922016 @default.
• W2082626692 countsByYear W20826266922017 @default.
• W2082626692 countsByYear W20826266922018 @default.
• W2082626692 countsByYear W20826266922021 @default.
• W2082626692 countsByYear W20826266922022 @default.
• W2082626692 countsByYear W20826266922023 @default.
• W2082626692 crossrefType "journal-article" @default.
• W2082626692 hasAuthorship W2082626692A5019565977 @default.
• W2082626692 hasAuthorship W2082626692A5026989459 @default.
• W2082626692 hasAuthorship W2082626692A5033468301 @default.
• W2082626692 hasAuthorship W2082626692A5035100064 @default.
• W2082626692 hasAuthorship W2082626692A5059806376 @default.
• W2082626692 hasAuthorship W2082626692A5067207199 @default.
• W2082626692 hasAuthorship W2082626692A5068697669 @default.
• W2082626692 hasAuthorship W2082626692A5070489074 @default.
• W2082626692 hasAuthorship W2082626692A5072784740 @default.

• next